Agents for treating metabolic bone diseases

Details Agents for treating metabolic bone diseases Agents for treating metabolic bone diseases

A - Human Necessities

61

K

A61K 38/16 (2006.01) A61K 38/17 (2006.01)

Patent

CA 2152023

A pharmaceutical composition for treating metabolic bone diseases which comprises as an active ingredient IL-1 receptor, a soluble fragment consisting of an extracellular domain of IL-1R or a fragment thereof derived from mammals. The composition has a bone resorption inhibiting activity and is useful for the therapy and prophylaxis of metabolic bone diseases.

Affiliated with

Also associated with

Rating

Agents for treating metabolic bone diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agents for treating metabolic bone diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for treating metabolic bone diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1592713